All News

Expert panelists delve into topics related to women's health and women's health care during the COVID-19 pandemic, including pregnancy and COVID-19 vaccine considerations and best practices for guiding decisions on birth control.

The results also showed they were nearly 20 times more effective at preventing hospitalizations from the virus for individuals older than 65 than a prior infection alone.

The results of a study show that individuals who received 3 doses of the BNT162b2 vaccine had a 93% lower risk of hospitalization than those who had just 2.

Agency gives green light to supplemental new drug application for repository corticotropin injection.

Among those who were infected with the delta variant (126), 25% were fully immunized and 38% were unvaccinated, study results show.

But the role of the pharmacy chain in health systems, primary care, and specialty is uncertain.

Ciltacabtagene autoleucel (cilta-cel) CAR T-cell therapy is currently being evaluated for the treatment of patients with relapsed and/or refractory multiple myeloma.

Overall vaccine efficacy was 54.6%, which met the pre-specified endpoint for success and showed benefit across 3 influenza seasons and all 8 countries.

When the mRNA was removed, these remained in the cell for a long time and were able to maintain their function, new study results show.

Study does not show clinically significant improvements in overall survival but does show benefits in secondary endpoints, which included rates of distant metastases, deaths due to prostate cancer, and PSA failure.

Durvalumab (Imfinzi, AstraZeneca), combined with standard-of-care chemotherapy, demonstrated a clinically meaningful benefit in patients with advanced biliary tract cancer.

Prurigo nodularis has one of the highest quality of life impacts of any inflammatory skin disease with intense, chronic itch.

Service opportunities and increasing demand for a highly skilled workforce as driving innovation.

The biggest advantage of med sync for a community pharmacy is the proactive selection of a date to have all the patient’s chronic medications filled simultaneously.

Study finds that 16.9% of stomach cancers, 11.9% of endometrial cancers, 11.0% of kidney cancers, 9.3% of colon cancers, 8.1% of esophageal cancers, 6.5% of female breast cancers, and 3.9% of urinary bladder cancers were associated with a low level of exercise.

Technician Sirena Maxwell discusses how non-pharmacist staff members are emerging as key personnel for a strategic shift toward revenue outside dispensing.

Proposed demonstration project could have a negative effect on people with certain conditions, such as stroke, traumatic brain injury, and spinal cord injury.

Metamucil increases the bulk of stool, an effect that helps to cause movement of the intestines.

Benralizumab (Fasenra) is indicated for the add-on maintenance treatment of patients with severe asthma aged 12 years and older and with an eosinophilic phenotype.

Lindsay Bealor Greenleaf, MBA, JD, Vice President of ADVI Health, discusses a new poll from the Kaiser Family Foundation that found that 83% of Americans believe the government should be allowed to negotiate lower drug prices, for both those on Medicare and in private insurance plans.

Deep vein thrombosis can occur with certain medical conditions that affect how the blood clots.

Mark Garofoli, director of Experiential Learning Program at WVU School of Pharmacy, discusses his CPhT 2021 conference presentation regarding the role and impact of pharmacy technicians on opioids in the pharmacy.

In a continuing quest to be a one-stop shop to pharmacy professionals and students, Pharmacy Times® has upped its game on the podcast front in 2021 and will continue to introduce more podcasts in 2022.

According to a press release from AbbVie, Vuity is the first and only FDA-approved eye drop to treat this condition, which affects nearly half of the US adult population.

The concentration of C. diff toxins in the stool was linked to how sick patients were at the time of diagnosis and was associated with adverse outcomes, including the risk of infection returning after treatment.

These biomarkers may be able to control inflammation in the body once infected with COVID-19 and can help determine the seriousness of the infection, the researchers noted.

Multiple strategies can be used to create an individualized approach to therapies and removing barriers for patients with cancer.

The study also found that certain E. coli cells in these microenvironments were able to survive phage treatment without acquiring genetic resistance.